Skip to main content
Full access
New Research
Published Online: 1 January 2014

Lower Gene Expression for KCNS3 Potassium Channel Subunit in Parvalbumin-Containing Neurons in the Prefrontal Cortex in Schizophrenia

Abstract

Objective

In schizophrenia, alterations in markers of cortical GABA neurotransmission are prominent in parvalbumin-containing neurons. Parvalbumin neurons selectively express KCNS3, the gene encoding the Kv9.3 potassium channel α-subunit. Kv9.3 subunits are present in voltage-gated potassium channels that contribute to the precise detection of coincident excitatory synaptic inputs to parvalbumin neurons. This distinctive feature of parvalbumin neurons appears important for the synchronization of cortical neural networks in γ-oscillations. Because impaired prefrontal cortical γ-oscillations are thought to underlie the cognitive impairments in schizophrenia, the authors investigated whether KCNS3 mRNA levels are altered in the prefrontal cortex of schizophrenia subjects.

Method

KCNS3 mRNA expression was evaluated by in situ hybridization in 22 matched pairs of schizophrenia and comparison subjects and by microarray analyses of pooled samples of individually dissected neurons that were labeled with Vicia villosa agglutinin (VVA), a parvalbumin neuron-selective marker, in a separate cohort of 14 pairs. Effects of chronic antipsychotic treatments on KCNS3 expression were tested in the prefrontal cortex of antipsychotic-exposed monkeys.

Results

By in situ hybridization, KCNS3 mRNA levels were 23% lower in schizophrenia subjects. At the cellular level, both KCNS3 mRNA-expressing neuron density and KCNS3 mRNA level per neuron were significantly lower. By microarray, KCNS3 mRNA levels were lower by 40% in VVA-labeled neurons from schizophrenia subjects. KCNS3 mRNA levels were not altered in antipsychotic-exposed monkeys.

Conclusions

These findings reveal lower KCNS3 expression in prefrontal cortical parvalbumin neurons in schizophrenia, providing a molecular basis for compromised detection of coincident synaptic inputs to parvalbumin neurons that could contribute to altered γ-oscillations and impaired cognition in schizophrenia.

Formats available

You can view the full content in the following formats:

Supplementary Material

Supplementary Material (62_ds001.pdf)

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 62 - 71
PubMed: 24170294

History

Received: 9 April 2013
Revision received: 3 July 2013
Accepted: 29 July 2013
Published online: 1 January 2014
Published in print: January 2014

Authors

Affiliations

Danko Georgiev, M.D., Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
Dominique Arion, Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
John F. Enwright, Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
Mitsuru Kikuchi, M.D., Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
Yoshio Minabe, M.D., Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
John P. Corradi, Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
David A. Lewis, M.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.
Takanori Hashimoto, M.D., Ph.D.
From the Department of Psychiatry and Neurobiology, Graduate School of Medical Science, and the Research Center for Child Mental Development, Kanazawa University, Kanazawa, Japan; the Departments of Psychiatry and Neuroscience, University of Pittsburgh, Pittsburgh; and the Department of Applied Genomics, Bristol-Myers Squibb, Wallingford, Conn.

Notes

Presented in part at the 34th annual meeting of the Japan Neuroscience Society, Yokohama, Japan, Sept. 14–17, 2011; and the 41st annual meeting of the Society for Neuroscience, Washington, D.C., November 12–16, 2011.
Address correspondence to Drs. Lewis and Hashimoto ([email protected] and [email protected]).

Funding Information

Dr. Lewis receives investigator-initiated research support from Bristol-Myers Squibb, Curridium, and Pfizer and has served as a consultant for Bristol-Myers Squibb and Concert Pharmaceuticals. Dr. Hashimoto has served as a consultant for Ono Pharmaceutical. The other authors report no financial relationships with commercial interests.
Supplementary Material
Supported by the Japan Society for the Promotion of Science (Kakenhi grant 24791207 to Dr. Georgiev and grants 21390332, 25116509, and 25293247 to Dr. Hashimoto); a grant from SENSHIN Medical Research Foundation (to Dr. Hashimoto); a grant from Research Group for Schizophrenia (to Dr. Hashimoto); NIH grants MH043784 and MH084053 (to Dr. Lewis); and a grant from Bristol-Myers Squibb (to Dr. Lewis).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share